Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Insulin_glargine> ?p ?o. }
Showing items 1 to 94 of
94
with 100 items per page.
- Insulin_glargine abstract "Insulin glargine, marketed by Sanofi-Aventis under the name Lantus, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert). Pharmacokinetically, it resembles basal insulin secretion of non-diabetic pancreatic beta cells. Sometimes, in type 2 diabetes and in combination with a short acting sulfonylurea (drugs which stimulate the pancreas to make more insulin), it can offer moderate control of serum glucose levels. In the absence of endogenous insulin—type 1 diabetes, depleted type 2 (in some cases) or latent autoimmune diabetes of adults in late stage—insulin glargine needs the support of fast acting insulin taken with food to reduce the effect of prandially derived glucose.".
- Insulin_glargine atcPrefix "A10".
- Insulin_glargine atcSuffix "AE04".
- Insulin_glargine casNumber "160337-95-1".
- Insulin_glargine drugbank "DB00047".
- Insulin_glargine fdaUniiCode "2ZM8CX04RZ".
- Insulin_glargine iupacName "Recombinant human insulin".
- Insulin_glargine wikiPageExternalLink dpdirect.jsp?name=Insulin+glargine.
- Insulin_glargine wikiPageExternalLink www.lantus.com.
- Insulin_glargine wikiPageExternalLink a600027.html.
- Insulin_glargine wikiPageExternalLink index.php?article=2116.
- Insulin_glargine wikiPageID "1719250".
- Insulin_glargine wikiPageRevisionID "595155632".
- Insulin_glargine atcPrefix "A10".
- Insulin_glargine atcSuffix "AE04".
- Insulin_glargine c "267".
- Insulin_glargine casNumber "160337".
- Insulin_glargine chemspiderid "NA".
- Insulin_glargine drugbank "DB00047".
- Insulin_glargine h "404".
- Insulin_glargine hasPhotoCollection Insulin_glargine.
- Insulin_glargine iupacName "Recombinant human insulin".
- Insulin_glargine kegg "D03250".
- Insulin_glargine legalUk "POM".
- Insulin_glargine legalUs "Rx-only".
- Insulin_glargine medlineplus "a600027".
- Insulin_glargine molecularWeight "6063".
- Insulin_glargine n "72".
- Insulin_glargine o "78".
- Insulin_glargine pregnancyUs "C".
- Insulin_glargine routesOfAdministration "Subcutaneous".
- Insulin_glargine s "6".
- Insulin_glargine tradename "Lantus".
- Insulin_glargine unii "2".
- Insulin_glargine verifiedfields "changed".
- Insulin_glargine verifiedrevid "458271727".
- Insulin_glargine subject Category:Human_proteins.
- Insulin_glargine subject Category:Insulin_therapies.
- Insulin_glargine subject Category:Peptide_hormones.
- Insulin_glargine subject Category:Recombinant_proteins.
- Insulin_glargine type Abstraction100002137.
- Insulin_glargine type Act100030358.
- Insulin_glargine type Activity100407535.
- Insulin_glargine type BodySubstance105263850.
- Insulin_glargine type Care100654885.
- Insulin_glargine type Chemical114806838.
- Insulin_glargine type Compound114818238.
- Insulin_glargine type Event100029378.
- Insulin_glargine type Hormone105407119.
- Insulin_glargine type HumanProteins.
- Insulin_glargine type InsulinTherapies.
- Insulin_glargine type LiquidBodySubstance105397468.
- Insulin_glargine type Macromolecule114944888.
- Insulin_glargine type Material114580897.
- Insulin_glargine type Matter100020827.
- Insulin_glargine type MedicalCare100657604.
- Insulin_glargine type Molecule114682133.
- Insulin_glargine type OrganicCompound114727670.
- Insulin_glargine type Part113809207.
- Insulin_glargine type PeptideHormones.
- Insulin_glargine type PhysicalEntity100001930.
- Insulin_glargine type Protein114728724.
- Insulin_glargine type PsychologicalFeature100023100.
- Insulin_glargine type RecombinantProtein114729633.
- Insulin_glargine type RecombinantProteins.
- Insulin_glargine type Relation100031921.
- Insulin_glargine type Secretion105404728.
- Insulin_glargine type Substance100019613.
- Insulin_glargine type Therapy100661091.
- Insulin_glargine type Thing100002452.
- Insulin_glargine type Treatment100658082.
- Insulin_glargine type Unit109465459.
- Insulin_glargine type Work100575741.
- Insulin_glargine type YagoPermanentlyLocatedEntity.
- Insulin_glargine type Drug.
- Insulin_glargine type DrugProduct.
- Insulin_glargine type FunctionalSubstance.
- Insulin_glargine comment "Insulin glargine, marketed by Sanofi-Aventis under the name Lantus, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert). Pharmacokinetically, it resembles basal insulin secretion of non-diabetic pancreatic beta cells.".
- Insulin_glargine label "Insulin glargin".
- Insulin_glargine label "Insulin glargine".
- Insulin_glargine label "Insulina glargine".
- Insulin_glargine label "Insuline glargine".
- Insulin_glargine sameAs Insulin_glargin.
- Insulin_glargine sameAs 인슐린_글라진.
- Insulin_glargine sameAs Insuline_glargine.
- Insulin_glargine sameAs Insulina_glargine.
- Insulin_glargine sameAs m.05qxx3.
- Insulin_glargine sameAs Q417317.
- Insulin_glargine sameAs Q417317.
- Insulin_glargine sameAs insulin_glargine.
- Insulin_glargine sameAs DB01308.
- Insulin_glargine sameAs Insulin_glargine.
- Insulin_glargine wasDerivedFrom Insulin_glargine?oldid=595155632.
- Insulin_glargine isPrimaryTopicOf Insulin_glargine.